{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:26:54Z","timestamp":1776702414049,"version":"3.51.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1378\/chest.128.2.940","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T06:51:39Z","timestamp":1123829499000},"page":"940-946","source":"Crossref","is-referenced-by-count":47,"title":["The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"128","author":[{"given":"Karl","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn S","family":"Tillotson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.128.2.940_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society; The Canadian Community-Acquired Pneumonia Working Group","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/18.4.501","article-title":"Community-acquired pneumonia","volume":"18","author":"Marrie","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.128.2.940_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1378\/chest.128.2.940_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.128.2.940_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1378\/chest.113.2.387","article-title":"Streptococcus pneumoniaebacteremia in a community hospital","volume":"113","author":"Torres","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.128.2.940_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513953","article-title":"Community-acquired pneumonia in adults: guidelines for management: the Infectious Diseases Society of America","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.2.940_bib9","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2003.08.004","article-title":"The epidemiology of antibiotic resistance inStreptococcus pneumoniaeand the clinical relevance of resistance to cephalosporins, macrolides and quinolones","volume":"22","author":"Pallares","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1378\/chest.128.2.940_bib10","first-page":"276","article-title":"Treatment of pneumococcal pneumonia","volume":"14","author":"Pallares","year":"1999","journal-title":"Semin Respir Infect"},{"key":"10.1378\/chest.128.2.940_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1378\/chest.128.2.940_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0924-8579(02)00127-9","article-title":"Clinical aspects and cost of invasiveStreptococcus pneumoniaeinfections in children: resistant vs susceptible strains","volume":"20","author":"Quach","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1378\/chest.128.2.940_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thx.56.suppl_4.iv1","article-title":"British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults","volume":"56","year":"2001","journal-title":"Thorax"},{"key":"10.1378\/chest.128.2.940_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumococcal macrolide resistance: myth or reality?","volume":"4","author":"Amsden","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.2.940_bib15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistantStreptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib16","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/AAC.48.9.3305-3311.2004","article-title":"In vitrosusceptibilities ofStreptococcus pneumoniaeclinical isolates observed in Canada in 2002","volume":"48","author":"Powis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.2.940_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0901.020277","article-title":"Maintaining fluoroquinolone class efficacy: review of influencing factors","volume":"9","author":"Scheld","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumoniae","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.128.2.940_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/322658","article-title":"A nosocomial outbreak of fluoroquinolones-resistantStreptococcus pneumoniae","volume":"33","author":"Weiss","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0954-6111(03)00166-5","article-title":"Sequetial IV\/PO moxifloxacin treatment of patients with severe community-acquired pneumonia","volume":"97","author":"Lode","year":"2003","journal-title":"Respir Med"},{"key":"10.1378\/chest.128.2.940_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkf509","article-title":"Antimicrobial susceptibility and pneumococcal serotypes","volume":"50","author":"Fenoll","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.2.940_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/48.3.407","article-title":"In vitroactivity of a novel ketolide ABT-773 against invasive strains ofStreptococcus pneumoniae","volume":"48","author":"Weiss","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.2.940_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0924-8579(00)00340-X","article-title":"Antibiotic resistance in the absence of selective pressure","volume":"17","author":"Gillespie","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1378\/chest.128.2.940_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be sub-optimal for severe bacteremic pneumococcal pneumoniae","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.128.2.940_bib26","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study; 1978\u20131997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"key":"10.1378\/chest.128.2.940_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactams regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1155\/2004\/461392","article-title":"Clinical characteristics at initial presentation, and impact of dual therapy on the outcome of bacteremicStreptococcus pneumoniaepneumonia in adults","volume":"11","author":"Weiss","year":"2004","journal-title":"Can Respir J"},{"key":"10.1378\/chest.128.2.940_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","article-title":"Multiple pathogens in adult patients admitted with community acquired pneumonia a one year prospective study of 346 consecutive patients","volume":"51","author":"Lieberman","year":"1996","journal-title":"Thorax"},{"key":"10.1378\/chest.128.2.940_bib30","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.1997.00440380069007","article-title":"Adult bacteremic pneumococcal pneumonia in a teaching hospital, 1992\u20131996: a detailed analysis of 108 cases","volume":"157","author":"Watanakunakorn","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.128.2.940_bib31","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.128.2.940_bib32","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.1997.03550230056037","article-title":"Quality of care, process, and outcomes in elderly patients with pneumonia","volume":"278","author":"Meehan","year":"1997","journal-title":"JAMA"},{"key":"10.1378\/chest.128.2.940_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm.156.1.9612065","article-title":"Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells","volume":"156","author":"Takizawa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.128.2.940_bib34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: a comparative observational study; The Canadian Streptococcal Study Group","volume":"4","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.47.3.1151-1153.2003","article-title":"Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniain vitro","volume":"47","author":"Lin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.2.940_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.128.2.940_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.2.940_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/48.1.67","article-title":"Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin","volume":"48","author":"File","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.2.940_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community acquired pneumonia","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.128.2.940_bib40","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1378\/chest.119.5.1439","article-title":"Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia","volume":"119","author":"Dresser","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.128.2.940_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1378\/chest.128.2.940_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JCM.33.3.596-601.1995","article-title":"Detection ofStreptococcus pneumoniaein whole blood by PCR","volume":"33","author":"Zhang","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.128.2.940_bib43","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JCM.39.10.3495-3498.2001","article-title":"Evaluation of a rapid immunochromatographic test for detection ofStreptococcus pneumoniaeantigen in urine samples from adults with community-acquired pneumonia","volume":"39","author":"Murdoch","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.128.2.940_bib44","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0149-2918(02)80088-1","volume":"24","author":"Lode","year":"2002","journal-title":"Clin Ther"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215504480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215504480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T22:32:25Z","timestamp":1586385145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215504480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0012369215504480"],"URL":"https:\/\/doi.org\/10.1378\/chest.128.2.940","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}